I read this to say that they are concerned about the science, the long term effects of treatment and also crisis management. They are not rushing into anything. Fortunately, LL has a long term safety profile and has demonstrated efficacy.
If they give us an EUA, then It will be contingent on us delivering product. Therefore, with our limited Inventory I wonder how far Cytodyn should take this considering the imminent opportunity that exists in the US.
News 
Market Data 
Discover 
AI
